CLINICAL_TRIALS
trial_result
· 2012-07-12
Clinical Trial Update: Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial evaluated lenalidomide in combination with GM-CSF for patients with prostate cancer; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Robert Dreicer MD | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-07-12